Status:
COMPLETED
Renal Denervation in Patients With Refractory Hypertension
Lead Sponsor:
Medtronic Vascular
Conditions:
Hypertension
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to investigate the clinical utility of renal denervation for the treatment of refractory hypertension.
Eligibility Criteria
Inclusion
- Systolic blood pressure of 160 mmHg or greater
- On 3 or more antihypertensive medications
- eGFR \>= 45 mL/min
Exclusion
- Renal artery abnormalities
- Known secondary hypertension attributable to a cause other than sleep apnea
- MI, angina, CVA within 6 months
- Type 1 diabetes
- Others
Key Trial Info
Start Date :
September 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2013
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT00753285
Start Date
September 1 2008
End Date
May 1 2013
Last Update
November 10 2014
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Prairie Heart Institute
Springfield, Illinois, United States, 62701
2
Hennepin County Medical Center
Minneapolis, Minnesota, United States, 55415
3
MetroHealth Medical Center
Cleveland, Ohio, United States, 44109